Trial Profile
Study of Efficacy and Safety of Presurgical Pazopanib Therapy in Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: a clinical multicentric prospective study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2017
Price :
$35
*
At a glance
- Drugs Pazopanib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 13 Nov 2017 New trial record